Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that the Management of the Company is scheduled to meet with the Analyst(s)/Institutional Investor(s) on 10-December 2025 to 11-December 2025 in Mumbai (In person/Virtual).
The above information is a part of company’s filings submitted to BSE.